Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Shares Outstanding (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Shares Outstanding for 7 consecutive years, with $87.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.49% to $87.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $87.8 million through Dec 2025, up 1.49% year-over-year, with the annual reading at $87.8 million for FY2025, 1.49% up from the prior year.
  • Shares Outstanding hit $87.8 million in Q4 2025 for IDEAYA Biosciences, roughly flat from $87.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $87.8 million in Q4 2025 to a low of $1.7 million in Q3 2024.
  • Historically, Shares Outstanding has averaged $56.8 million across 5 years, with a median of $52.9 million in 2023.
  • Biggest five-year swings in Shares Outstanding: soared 58.6% in 2021 and later grew 1.49% in 2025.
  • Year by year, Shares Outstanding stood at $38.5 million in 2021, then increased by 25.07% to $48.2 million in 2022, then skyrocketed by 34.96% to $65.0 million in 2023, then skyrocketed by 33.0% to $86.5 million in 2024, then rose by 1.49% to $87.8 million in 2025.
  • Business Quant data shows Shares Outstanding for IDYA at $87.8 million in Q4 2025, $87.7 million in Q3 2025, and $87.6 million in Q2 2025.